<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66277</article-id><article-id pub-id-type="doi">10.7554/eLife.66277</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title><italic>Plasmodium falciparum</italic> K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-223304"><name><surname>Stokes</surname><given-names>Barbara H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223307"><name><surname>Dhingra</surname><given-names>Satish K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223305"><name><surname>Rubiano</surname><given-names>Kelly</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4149-4030</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155835"><name><surname>Mok</surname><given-names>Sachel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9605-0154</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223306"><name><surname>Straimer</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223308"><name><surname>Gnadig</surname><given-names>Nina F</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223310"><name><surname>Deni</surname><given-names>Ioanna</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5266-8243</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242775"><name><surname>Schindler</surname><given-names>Kyra A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223309"><name><surname>Bath</surname><given-names>Jade R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223311"><name><surname>Ward</surname><given-names>Kurt E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3614-436X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223312"><name><surname>Striepen</surname><given-names>Josefine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223313"><name><surname>Yeo</surname><given-names>Tomas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2923-6060</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223314"><name><surname>Ross</surname><given-names>Leila S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223315"><name><surname>Legrand</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223316"><name><surname>Ariey</surname><given-names>Frédéric</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223317"><name><surname>Cunningham</surname><given-names>Clark H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223318"><name><surname>Souleymane</surname><given-names>Issa M</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223319"><name><surname>Gansané</surname><given-names>Adama</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223320"><name><surname>Nzoumbou-Boko</surname><given-names>Romaric</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223321"><name><surname>Ndayikunda</surname><given-names>Claudette</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223322"><name><surname>Kabanywanyi</surname><given-names>Abdunoor M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2980-0429</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223331"><name><surname>Uwimana</surname><given-names>Aline</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223324"><name><surname>Smith</surname><given-names>Samuel J</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223325"><name><surname>Kolley</surname><given-names>Olimatou</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223326"><name><surname>Ndounga</surname><given-names>Mathieu</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223327"><name><surname>Warsame</surname><given-names>Marian</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209643"><name><surname>Leang</surname><given-names>Rithea</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35030"><name><surname>Nosten</surname><given-names>François</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7951-0745</contrib-id><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174281"><name><surname>Anderson</surname><given-names>Timothy</given-names></name><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97545"><name><surname>Rosenthal</surname><given-names>Phillip J</given-names></name><xref ref-type="aff" rid="aff19">19</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206515"><name><surname>Menard</surname><given-names>Didier</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-140096"><name><surname>Fidock</surname><given-names>David A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6753-8938</contrib-id><xref ref-type="aff" rid="aff20">20</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Microbiology and Immunology</institution>, <institution>Columbia University Irving Medical Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Molecular Microbiology</institution>, <institution>Washington University in St. Louis</institution>, <addr-line><named-content content-type="city">St. louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>Columbia University Irving Medical Center</institution>, <addr-line><named-content content-type="city">New Yok</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Malaria Genetics and Resistance Unit, INSERM U1201</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution content-type="dept">Inserm U1016</institution>, <institution>Institut Cochin</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff6"><institution content-type="dept">Lutte Contre le Paludisme</institution>, <institution>Programme National de</institution>, <addr-line><named-content content-type="city">Ndjamena</named-content></addr-line>, <country>Chad</country></aff><aff id="aff7"><institution content-type="dept">de Recherche et de Formation sur le Paludisme</institution>, <institution>Centre National</institution>, <addr-line><named-content content-type="city">Ouagadougou</named-content></addr-line>, <country>Burkina Faso</country></aff><aff id="aff8"><institution content-type="dept">Laboratory of Parasitology</institution>, <institution>Institute Pasteur of Bangui</institution>, <addr-line><named-content content-type="city">Bangui</named-content></addr-line>, <country>Central African Republic</country></aff><aff id="aff9"><institution content-type="dept">Parasitology</institution>, <institution>University Teaching Hospital of Kamenge</institution>, <addr-line><named-content content-type="city">Bujumbura</named-content></addr-line>, <country>Burundi</country></aff><aff id="aff10"><institution content-type="dept">Parasitology</institution>, <institution>Ifakara Health Institute</institution>, <addr-line><named-content content-type="city">Dar es Salaam</named-content></addr-line>, <country>Kenya</country></aff><aff id="aff11"><institution content-type="dept">Malaria and Other Parasitic Diseases Division</institution>, <institution>Rwanda Biomedical Centre</institution>, <addr-line><named-content content-type="city">Kigali</named-content></addr-line>, <country>Rwanda</country></aff><aff id="aff12"><institution content-type="dept">National Malaria Control Programme</institution>, <institution>National Malaria Control Programme</institution>, <addr-line><named-content content-type="city">Freetown</named-content></addr-line>, <country>Sierra Leone</country></aff><aff id="aff13"><institution content-type="dept">National Malaria Control Program</institution>, <institution>National Malaria Control Program</institution>, <addr-line><named-content content-type="city">Banjul</named-content></addr-line>, <country>Gambia</country></aff><aff id="aff14"><institution content-type="dept">Programme National de Lutte Contre le Paludisme</institution>, <institution>Programme National de Lutte Contre le Paludisme</institution>, <addr-line><named-content content-type="city">Brazzaville</named-content></addr-line>, <country>Democratic Republic of the Congo</country></aff><aff id="aff15"><institution content-type="dept">School of Public Health and Community Medicine</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff16"><institution content-type="dept">National Center for Parasitology, Entomology, and Malaria Control</institution>, <institution>National Center for Parasitology, Entomology, and Malaria Control</institution>, <addr-line><named-content content-type="city">Phnom Penh</named-content></addr-line>, <country>Cambodia</country></aff><aff id="aff17"><institution content-type="dept">Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine</institution>, <institution>Mahidol University</institution>, <addr-line><named-content content-type="city">Mae Sot</named-content></addr-line>, <country>Thailand</country></aff><aff id="aff18"><institution>Texas Biomedical Research Institute</institution>, <addr-line><named-content content-type="city">San Antonio</named-content></addr-line>, <country>United States</country></aff><aff id="aff19"><institution content-type="dept">Department of Medicine</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff20"><institution content-type="dept">Microbiology and Immunology</institution>, <institution>Columbia University Medical Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-41647"><name><surname>Soldati-Favre</surname><given-names>Dominique</given-names></name><role>Reviewing editor</role><aff><institution>University of Geneva</institution>, <country>Switzerland</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>df2260@cumc.columbia.edu</email> (DF);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>07</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66277</elocation-id><history><date date-type="received"><day>05</day><month>01</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Stokes et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Stokes et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66277-v1.pdf"/><abstract><p>The emergence of mutant K13-mediated artemisinin (ART) resistance in <italic>Plasmodium falciparum </italic>malaria parasites has led to widespread treatment failure across Southeast Asia. In Africa, <italic>K13-</italic>propeller genotyping confirms the emergence of the R561H mutation in Rwanda and highlights the continuing dominance of wild-type K13 elsewhere. Using gene editing, we show that R561H, along with C580Y and M579I, confer elevated <italic>in vitro</italic> ART resistance in some African strains, contrasting with minimal changes in ART susceptibility in others. C580Y and M579I cause substantial fitness costs, which may slow their dissemination in high-transmission settings, in contrast with R561H that in African 3D7 parasites is fitness neutral. In Cambodia, <italic>K13</italic> genotyping highlights the increasing spatio-temporal dominance of C580Y. Editing multiple K13 mutations into a panel of Southeast Asian strains reveals that only the R561H variant yields ART resistance comparable to C580Y. In Asian Dd2 parasites C580Y shows no fitness cost, in contrast with most other K13 mutations tested, including R561H. Editing point mutations in <italic>ferredoxin</italic> or <italic>mdr2</italic>, earlier associated with resistance, has no impact on ART susceptibility or parasite fitness. These data underline the complex interplay between K13 mutations, parasite survival, growth and genetic background in contributing to the spread of ART resistance.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>P. falciparum</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01 AI109023</award-id><principal-award-recipient><name><surname>Fidock</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>W81XWH1910086</award-id><principal-award-recipient><name><surname>Fidock</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>OPP1201387</award-id><principal-award-recipient><name><surname>Fidock</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>106698</award-id><principal-award-recipient><name><surname>Nosten</surname><given-names>François</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R37 AI048071</award-id><principal-award-recipient><name><surname>Anderson</surname><given-names>Timothy</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>T32 AI106711</award-id><principal-award-recipient><name><surname>Fidock</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004423</institution-id><institution>World Health Organization</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Menard</surname><given-names>Didier</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004423</institution-id><institution>World Health Organization</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fidock</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Health care facilities were in charge of collecting anonymized P. falciparum positive cases. Identification of individuals cannot be established. The studies were approved by ethics committees listed in Supplementary file 1. We note that the sponsors had no role in the study design or in the collection or analysis of the data. There was no confidentiality agreement between the sponsors and the investigators.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1-7.</p></sec><supplementary-material><ext-link xlink:href="elife-66277-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>